Type your tag names separated by a space and hit enter

Tetanus

Tetanus is a topic covered in the 5-Minute Emergency Consult.

To view the entire topic, please or purchase a subscription.

Emergency Central is a collection of disease, drug, and test information including 5-Minute Emergency Medicine Consult, Davis’s Drug, McGraw-Hill Medical’s Diagnosaurus®, Pocket Guide to Diagnostic Tests, and MEDLINE Journals created for emergency medicine professionals. Explore these free sample topics:

Emergency Central

-- The first section of this topic is shown below --

Basics

Description

  • Rare disease in US but still prevalent in 3rd-world countries
  • About 30 cases per year in US
  • One-half of the cases involve people >50 yr of age
  • Majority of cases in US occur in the unvaccinated, >10 yr since last booster or IVDUs
  • 500,000–1,000,000 cases worldwide
  • High mortality rates even with treatment
  • Incubation period:
    • Inoculation to the appearance of the 1st symptoms:
      • 48 hr to 3 wk or more
    • Period of onset:
      • <7 days—poor prognosis
      • Very poor prognosis if <48 hr from 1st symptom to initial reflex spasm
  • Neonatal tetanus:
    • Due to infected umbilical stump
    • Symptom onset in 2nd week of life when maternal antibodies decrease
    • Rare in US but common in 3rd-world countries
    • Worldwide, accounts for over one-half of all tetanus infections

Etiology

  • Clostridium tetani:
    • Slender, motile, heat-sensitive, anaerobic gram-positive rod with a terminal spherical spore
    • Spore characteristics
    • Resistant to oxygen, moisture, temperature extremes
    • Can survive indefinitely until it germinates
    • Ubiquitous in soil and feces
  • When inoculated into a wound or devitalized tissue or injected IV as a contaminant of street drugs, the spores germinate under anaerobic conditions and produce 2 toxins.
  • Toxins:
    • Tetanolysin:
      • Damages tissue
      • Does not cause clinical manifestations of tetanus infection
    • Tetanospasmin:
      • Powerful neurotoxin
      • Disrupts the release of neurotransmitters such as γ-aminobutyric acid (GABA)
      • Responsible for the clinical manifestations
  • Muscle spasms
  • Autonomic instability
  • Uncontrolled motor activity

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

Rosen, Peter, et al., editors. "Tetanus." 5-Minute Emergency Consult, 5th ed., Lippincott Williams & Wilkins, 2016. Emergency Central, emergency.unboundmedicine.com/emergency/view/5-Minute_Emergency_Consult/307627/all/Tetanus.
Tetanus. In: Rosen P, Shayne P, Barkin AZ, et al, eds. 5-Minute Emergency Consult. 5th ed. Lippincott Williams & Wilkins; 2016. https://emergency.unboundmedicine.com/emergency/view/5-Minute_Emergency_Consult/307627/all/Tetanus. Accessed April 23, 2019.
Tetanus. (2016). In Rosen, P., Shayne, P., Barkin, A. Z., Wolfe, R. E., Hayden, S. R., Barkin, R. M., & Schaider, J. J. (Eds.), 5-Minute Emergency Consult. Available from https://emergency.unboundmedicine.com/emergency/view/5-Minute_Emergency_Consult/307627/all/Tetanus
Tetanus [Internet]. In: Rosen P, Shayne P, Barkin AZ, Wolfe RE, Hayden SR, Barkin RM, Schaider JJ, editors. 5-Minute Emergency Consult. Lippincott Williams & Wilkins; 2016. [cited 2019 April 23]. Available from: https://emergency.unboundmedicine.com/emergency/view/5-Minute_Emergency_Consult/307627/all/Tetanus.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Tetanus ID - 307627 ED - Rosen,Peter, ED - Shayne,Philip, ED - Barkin,Adam Z, ED - Wolfe,Richard E, ED - Hayden,Stephen R, ED - Barkin,Roger M, ED - Schaider,Jeffrey J, BT - 5-Minute Emergency Consult UR - https://emergency.unboundmedicine.com/emergency/view/5-Minute_Emergency_Consult/307627/all/Tetanus PB - Lippincott Williams & Wilkins ET - 5 DB - Emergency Central DP - Unbound Medicine ER -